This page contains information about Novo Nordisk products.

 
 
 

NordiSure – helping your patients afford Norditropin® [somatropin (rDNA origin) injection]

An innovative solution that helps offset patient out-of-pocket expenses

You are committed to your patients reaching their goals, and we want to help. Whether a patient is new to therapy, switching to Norditropin®, or continuing treatment with Norditropin®, financial issues should not stand in the way.

NordiSure is used to reduce your copayment or coinsurance for Norditropin®. It covers up to $125 per moth of therapy for up to one year of copayments. Depending on your specific insurance plan, NordiSure may cover your copayment. You may re-enroll after one year.

All you have to do is let your patient know about the program, or ask NordiCare® to contact a patient who is interested in the program. NordiSure covers naïve, recently switched, and existing patients with private insurance or those who self-pay. Some limitations apply.

Helping your patients is as easy as 1-2-3

There are three easy steps to helping your patients access NordiSure services:

  1. You can provide the NordiSure brochure to your patients and ask that they contact NordiCare® directly.
  2. If you are submitting a Statement of Medical Necessity (SMN) for your patient, write “NordiSure” on the SMN.
  3. Alternatively, call your NordiCare® Case Manager at 1-888-668-6444 and NordiCare® will continue the process to enroll eligible patients, communicate enrollment to a specialty pharmacy, and deliver a pre-activated debit card and instructions to your patient.

For more information about NordiSure, contact your NordiCare® Case Manager at 1-888-668-6444

* Eighty-five percent (85%) of patients taking Norditropin® have copayments of less than $125 per month.1

NordiSure Terms and Conditions
Card covers costs including but not limited to copay/coinsurance up to $125 per month of therapy for a period of 12 months to a maximum of $1500. Card may be used no more frequently than every 21 days. Card is not valid for prescriptions that are eligible to be reimbursed by private insurance plans or other health or pharmacy benefit programs that reimburse the patient for the entire cost of his/her prescription drugs. Not valid for prescriptions that are eligible to be reimbursed, in whole or in part, by Medicaid, Medicare (including Medicare Part D), or other federal or state programs (including any state prescription drug assistance programs). Not valid for residents of Massachusetts or Vermont. The program cannot be combined with any other rebate/coupon, free trial, or similar offer for the specified prescription. Offer good only in the United States. Novo Nordisk reserves the right to rescind, revoke, or amend this offer without notice at any time.

References

  1. Data on file. 2009 NordiCare® copay analysis. Princeton, NJ: Novo Nordisk Inc; 2009.